M. Chesser

Schedule and dosage modification of a cyclophosphamide, hexamethylmelamine, doxorubicin, cisplatin combination chemotherapy regimen for refractory ovarian cancer.

E. Feuer, J. Holland, H. Bruckner, 1989, European journal of cancer & clinical oncology.

Survival after combined modality therapy for pancreatic cancer.

S. Kalnicki, N. Harpaz, G. Schwartz, 1993, Journal of clinical gastroenterology.

Combined modality therapy for stage II and stage III pancreatic carcinoma.

A. Cooperman, J. Morris, H. Bruckner, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Circulating pancreatic polypeptide in patients with adenocarcinoma of the bile duct.

H. Bruckner, J. Mandeli, L. Farber, 1993, Acta oncologica.

Dose-dependent leucovorin efficacy with an intermittent high-dose 5-fluorouracil schedule.

H. Bruckner, L. Glass, M. Chesser, 1990, Cancer Investigation.

Hexamethylmelamine for the treatment of ovarian cancer--the Mount Sinai experience.

C. Cohen, J. Holland, H. Bruckner, 1991, Cancer treatment reviews.

Identifying High-Risk Workspaces during COVID-19 using Machine Learning

Erin Carrier, Lex Drennan, Matthew Chesser, 2021, FLAIRS.